Targeting Inflammation in Acute Coronary Syndrome Using Colchicine

Phase 2/3 Completed 80 enrolled Hamilton Health Sciences Corporation

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of colchicine on high sensitivity C-reactive protein (hs-CRP), a blood marker to measure inflammation, in patients with acute coronary syndromes.

Timeline

Start: 2008-04
Primary completion: 2009-09
Completion: 2009-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Colchicine	Small molecule	1 mg	Oral

Targeting Inflammation in Acute Coronary Syndrome Using Colchicine

Summary

Timeline

Drugs

Indications